The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study

Table 2

Results of MCCG in different groups.

	Abdominal pain; ()	Abdominal bloating; ()	Reflux symptoms; ()	Follow-ups; ()	Bleeding; ()
Sex (M/F)	214/328	663/736	63/81	78/77	42/36
Age (years)#	38 (19 ~ 81)^#	42 (19 ~94)^#	41 (24 ~ 80)^#	46 (24 ~ 87)^#	52 (25 ~ 87)^#
Gastric ulcer	65	119	11	15	14
Duodenal ulcer	14	31	0	4	3
Jejuno-ileal ulcer	24	20	0	9	7
Esophagitis	1	8	17	0	0
Barrett’s esophagus	2	6	7	1	0
Gastric SMT	4	18	0	1	1
SBST	0	1	0	0	1
Gastric polyp (antrum/fundus or body)	3/14	40/63	1/4	4/7	0/2
Duodenal polyp	0	6	2	1	0
Jejuno-ileal polyp	1	11	0	1	2
Suspected lesion	8	41	3	6	4

^#Present with median (min ~ max). Suspicious morphology, patients are referred to undergo C-EGD or EUS to further confirm the diagnosis. MCCG: magnetic-controlled capsule gastroscopy; C-EGD: conventional esophagogastroduodenoscopy; SMT: submucosal tumor; SBST: small bowel stromal tumors.